Cargando…
The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone
The aim of the present study was to evaluate the potential antidiabetic effects of two-component drug Subetta and its components (release-active dilutions of antibodies to β-subunit insulin receptor (RAD of Abs to β-InsR) and to endothelial nitric oxide synthase (RAD of Abs to eNOS)) in Goto-Kakizak...
Autores principales: | Bailbé, Danielle, Philippe, Erwann, Gorbunov, Evgeniy, Tarasov, Sergey, Epstein, Oleg, Portha, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665238/ https://www.ncbi.nlm.nih.gov/pubmed/23762875 http://dx.doi.org/10.1155/2013/763125 |
Ejemplares similares
-
Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”
Publicado: (2019) -
Subetta Treatment Increases Adiponectin Secretion by Mature Human Adipocytes In Vitro
por: Nicoll, Jim, et al.
Publicado: (2013) -
Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats
por: Zhen, Delong, et al.
Publicado: (2023) -
The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome
por: Bourgneuf, Camille, et al.
Publicado: (2021) -
Insulin Resistance Is Not Associated with an Impaired Mitochondrial Function in Contracting Gastrocnemius Muscle of Goto-Kakizaki Diabetic Rats In Vivo
por: Macia, Michael, et al.
Publicado: (2015)